LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Pathway Leads to Skin and Hair Regeneration After Injury

By LabMedica International staff writers
Posted on 25 Aug 2015
Print article
Image: Skin cells (keratinocytes) treated with an agent that activates TLR3 (dsRNA) can turn on important regeneration proteins, like Wnt7b (green) (Photo courtesy of Johns Hopkins University).
Image: Skin cells (keratinocytes) treated with an agent that activates TLR3 (dsRNA) can turn on important regeneration proteins, like Wnt7b (green) (Photo courtesy of Johns Hopkins University).
The ability of the skin to regenerate after injury has been linked to stimulation of Toll-Like Receptor 3 (TLR3) by double-stranded RNA (dsRNA) released by the damaged skin.

Replacement of skin and hair follicles after wounding through a process known as wound-induced hair neogenesis (WIHN) is a rare example of adult organ regeneration in mammals. As such, WIHN provides a unique model system for deciphering mechanisms underlying mammalian regeneration.

Investigators at Johns Hopkins University (Baltimore, MD, USA) used mouse models to study skin and hair follicle regeneration. Initially, by comparing normal mice to an inbred strain with restricted ability to regenerate skin, they found that expression of TLR3 was three times higher in the normal animals.

The application of synthetic dsRNA to mouse skin wounds led to a greater number of regenerated follicles. In contrast, treatment with a substance that broke up dsRNA decreased the number of regenerated follicles, and regeneration was nearly abolished in mice deficient in TLR3.

Results published in the August 6, 2015, issue of the journal Cell Stem Cell revealed that the process that began with dsRNA activation of TLR3 continued to hair follicle regeneration through the action of TLR3's downstream effectors IL-6 (interleukin-6) and STAT3 (signal transducer and activator of transcription 3). Loss of TLR3, IL-6Ra, or Stat3 proteins reduced WHIN in mice with damaged skin.

“Our study uncovers a novel role for a protein that works as a master regulator of regeneration in the skin,” said senior author Dr. Luis A. Garza, associate professor of dermatology at Johns Hopkins University. “Medications that turn on this protein have the powerful potential to decrease scarring as healing of wounds takes place, thereby promoting skin and hair follicle regeneration.”

“A lot of human disability is from scarring,” said Dr. Garza. “After a heart attack, we are really good at replacing the blood flow, but it is the scar on the heart afterward that is the real problem. We and others in the field of regenerative medicine are interested in how to enhance or trigger regeneration in such situations.”

Related Links:
Johns Hopkins University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more